SearchDictionaryMobileLogin

Controlled Hypotension

Subscribe to Selected New Research on Controlled Hypotension
238  relevant articles (5 outcomes, 4 trials/studies) found for this Therapy
Also Known As:
Hypotension, Controlled

Relationship Network

Therapy Context: Research Results

-
Anesthesia and Analgesia: 60
*
Controlled Hypotension: 238

Experts

1. Othman, I S: 1 article (11/2008)
2. Yosry, M: 1 article (11/2008)
3. de Miquel, M A: 1 article (12/2003)
4. Cambra, R: 1 article (12/2003)
5. Martí Valeri, C: 1 article (12/2003)
6. Gabarrós, A: 1 article (12/2003)
7. Alonso, P: 1 article (12/2003)
8. Ornaque, I: 1 article (12/2003)
9. Conesa, G: 1 article (12/2003)
10. Kowalczyk, Piotr: 1 article (01/2002)

Related Diseases

1. Hemorrhage
2. Aneurysm (Aneurysms)
3. Metrorrhagia (Spotting)
4. Melanoma (Melanoma, Malignant)
5. Hypotension (Low Blood Pressure)
12/01/2002 - "Therefore, we performed this study to evaluate the effect of normovolemic hypotension on characteristics of plethysmographic waveform in 33 adult patients undergoing general anesthesia with controlled hypotension"
10/01/2002 - "In patient care, several concepts exist for the reduction of blood loss in conjunction with systemic hypotension: these involve "deliberate hypotension" (synonym "controlled hypotension", used intraoperatively under conditions of normovolemia and stable hemodynamics), "delayed resuscitation" (where the hypotensive period is intentionally prolonged until operative intervention), and "permissive hypotension" (synonym "hypotensive resuscitation", where all kinds of therapy are commenced including fluid therapy, thereby increasing systemic pressure without, however, reaching normotension)"
01/01/2002 - "Controlled hypotension (also referred to as deliberate or induced hypotension), defined as a reduction of systolic blood pressure to 80 to 90 mm Hg, a reduction of mean arterial pressure (MAP) to 50 to 65 mm Hg or a 30% reduction of baseline MAP, is one technique that has been used to limit intraoperative blood loss"
10/21/2000 - "The main differences between concepts for the reduction of blood loss in systemic hypotension are between "deliberate hypotension" (synonym "controlled hypotension", used intraoperatively), "delayed resuscitation" (where the hypotensive period is intentionally prolonged until operative intervention) and "permissive hypotension" (where restrictive fluid therapy increases systemic pressure without reaching normotension)"
05/01/1999 - "Controlled hypotension to a mean arterial pressure (MAP) of 60 mm Hg was induced and maintained by inhalation of either anesthetic, lasting for 60 min. Measurements were made at baseline, 15 min (T1), and 60 min (T2) after starting hypotension, and 30 min after discontinuing equihypotension (T3)"
Order ALL the reference details at left...

Related Drugs and Biologics

1. Nitroprusside (Sodium Nitroprusside)
2. Alfentanil (Alfenta)
3. Magnesium
4. Ganglionic Blockers
5. remifentanil (Ultiva)
6. pentamine (azamethonium bromide)
7. Isoflurane
8. Propofol (Diprivan)
9. Fentanyl (Sublimaze)
10. Adenosine

Related Therapies and Procedures

1. General Anesthesia
2. Prostatectomy (Retropubic Prostatectomy)
3. Anesthesia
4. Ligation
5. Hemodilution

Best Treatments:
Research Summary Report
on Hemorrhage

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 2879 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>